In Brief

In Brief

Cedars-Sinai Cancer Stem Cell Transplant and Cellular Therapy Program receives expanded accreditation, top ranking for survival rates

The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recognized with official accreditation for CAR T-cell therapy from the Foundation for the Accreditation of Cellular Therapy, an international accrediting body. The program was also ranked among the top adult bone marrow transplant programs in the U.S. for a third year.